| Targeting the indoleamine 2, 3-dioxygenase pathway in cancer YW Moon, J Hajjar, P Hwu, A Naing Journal for immunotherapy of cancer 3, 1-10, 2015 | 361 | 2015 |
| Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experience T Fujii, RR Colen, MA Bilen, KR Hess, J Hajjar, ME Suarez-Almazor, ... Investigational new drugs 36, 638-646, 2018 | 166 | 2018 |
| Phase 2 study of pembrolizumab in patients with advanced rare cancers A Naing, F Meric-Bernstam, B Stephen, DD Karp, J Hajjar, JR Ahnert, ... Journal for immunotherapy of cancer 8 (1), 2020 | 132 | 2020 |
| Radiomics to predict immunotherapy-induced pneumonitis: proof of concept RR Colen, T Fujii, MA Bilen, A Kotrotsou, S Abrol, KR Hess, J Hajjar, ... Investigational new drugs 36, 601-607, 2018 | 111 | 2018 |
| Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency I Petrache, J Hajjar, M Campos Biologics: targets & therapy 3, 193, 2009 | 103 | 2009 |
| T-cell agonists in cancer immunotherapy Y Choi, Y Shi, CL Haymaker, A Naing, G Ciliberto, J Hajjar Journal for immunotherapy of cancer 8 (2), 2020 | 101 | 2020 |
| Use of genetic testing for primary immunodeficiency patients JR Heimall, D Hagin, J Hajjar, SE Henrickson, HS Hernandez-Trujillo, ... Journal of clinical immunology 38, 320-329, 2018 | 98 | 2018 |
| Diagnostic interpretation of genetic studies in patients with primary immunodeficiency diseases: a working group report of the Primary Immunodeficiency Diseases Committee of … IK Chinn, AY Chan, K Chen, J Chou, MJ Dorsey, J Hajjar, AM Jongco III, ... Journal of Allergy and Clinical Immunology 145 (1), 46-69, 2020 | 85 | 2020 |
| Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment NL Rider, C Kutac, J Hajjar, C Scalchunes, FO Seeborg, M Boyle, ... Journal of clinical immunology 37, 461-475, 2017 | 80 | 2017 |
| Biomarkers of response to immune checkpoint blockade in cancer treatment T Fujii, A Naing, C Rolfo, J Hajjar Critical reviews in oncology/hematology 130, 108-120, 2018 | 78 | 2018 |
| Strategies for improving the management of immune-related adverse events A Naing, J Hajjar, JL Gulley, MB Atkins, G Ciliberto, F Meric-Bernstam, ... Journal for immunotherapy of cancer 8 (2), 2020 | 69 | 2020 |
| Metformin: an old drug with new potential J Hajjar, MA Habra, A Naing Expert opinion on investigational drugs 22 (12), 1511-1517, 2013 | 53 | 2013 |
| Development and initial validation of a questionnaire to measure health-related quality of life of adults with common variable immune deficiency: the CVID_QoL questionnaire I Quinti, F Pulvirenti, P Giannantoni, J Hajjar, DL Canter, C Milito, D Abeni, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (6), 1169-1179. e4, 2016 | 43 | 2016 |
| Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers RR Colen, C Rolfo, M Ak, M Ayoub, S Ahmed, N Elshafeey, P Mamindla, ... Journal for immunotherapy of cancer 9 (4), 2021 | 42 | 2021 |
| Constrained chromatin accessibility in PU. 1-mutated agammaglobulinemia patients C Le Coz, DN Nguyen, C Su, BE Nolan, AV Albrecht, S Xhani, D Sun, ... Journal of Experimental Medicine 218 (7), e20201750, 2021 | 40 | 2021 |
| Increased incidence of fatigue in patients with primary immunodeficiency disorders: prevalence and associations within the US immunodeficiency network registry J Hajjar, D Guffey, CG Minard, JS Orange Journal of clinical immunology 37, 153-165, 2017 | 35 | 2017 |
| Associations between the gut microbiome and fatigue in cancer patients J Hajjar, T Mendoza, L Zhang, S Fu, SA Piha-Paul, DS Hong, F Janku, ... Scientific Reports 11 (1), 5847, 2021 | 34 | 2021 |
| Immunotherapy A Naing, J Hajjar Springer, 2017 | 30 | 2017 |
| Improved diagnostic clarity in shrimp allergic non–dust-mite sensitized patients KTS Tuano, S Anvari, IC Hanson, J Hajjar, F Seeborg, LM Noroski, ... Allergy and Asthma Proceedings 39 (5), 377, 2018 | 26 | 2018 |
| Rubella virus infected macrophages and neutrophils define patterns of granulomatous inflammation in inborn and acquired errors of immunity L Perelygina, R Faisthalab, E Abernathy, M Chen, LJ Hao, L Bercovitch, ... Frontiers in immunology 12, 796065, 2021 | 24 | 2021 |
Funda Meric-BernstamChair, Department of Investigational Cancer Therapeutics, The UT MD Anderson Cancer Center在 mdanderson.org 的电子邮件经过验证
